Literature DB >> 28722143

Breast cancer stem cells as last soldiers eluding therapeutic burn: A hard nut to crack.

Pritish Nilendu1, Ajay Kumar1, Azad Kumar1, Jayanta K Pal1, Nilesh Kumar Sharma1.   

Abstract

Cancer stem cells (CSCs) are found in many cancer types, including breast carcinoma. Breast cancer stem cells (BCSCs) are considered as seed of cancer formation and they are associated with metastasis and genotoxic drug resistance. Several studies highlighted the presence of BCSCs in tumor microenvironment and they are accentuated with several carcinoma events including metastasis and resistance to genotoxic drugs and they also rebound after genotoxic burn. Stemness properties of a small population of cells in carcinoma have provided clues regarding the role of tumor microenvironment in tumor pathophysiology. Hence, insights in cancer stem cell biology with respect to molecular signaling, genetics and epigenetic behavior of CSCs have been used to modulate tumor drug resistance due to genotoxic drugs and signaling protein inhibitors. This review summarizes major scientific breakthroughs in understanding the contribution of BCSCs towards tumor's capability to endure destruction inflicted by molecular as well as genotoxic drugs.
© 2017 UICC.

Entities:  

Keywords:  DNA damage; biomarkers; carcinoma; chemotherapy; genomic instability; growth signaling; microenvironment; stem cell

Mesh:

Year:  2017        PMID: 28722143     DOI: 10.1002/ijc.30898

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

Review 1.  Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance.

Authors:  Pritish Nilendu; Sachin C Sarode; Devashree Jahagirdar; Ishita Tandon; Shankargouda Patil; Gargi S Sarode; Jayanta K Pal; Nilesh Kumar Sharma
Journal:  Cell Oncol (Dordr)       Date:  2018-07-19       Impact factor: 6.730

Review 2.  Modulating secreted components of tumor microenvironment: A masterstroke in tumor therapeutics.

Authors:  Himadri Patel; Pritish Nilendu; Devashree Jahagirdar; Jayanta K Pal; Nilesh Kumar Sharma
Journal:  Cancer Biol Ther       Date:  2017-12-08       Impact factor: 4.742

Review 3.  Targeting bromodomain and extraterminal proteins in breast cancer.

Authors:  Jennifer M Sahni; Ruth A Keri
Journal:  Pharmacol Res       Date:  2017-11-16       Impact factor: 7.658

4.  Caveolin-1 inhibits breast cancer stem cells via c-Myc-mediated metabolic reprogramming.

Authors:  Shengqi Wang; Neng Wang; Yifeng Zheng; Bowen Yang; Pengxi Liu; Fengxue Zhang; Min Li; Juxian Song; Xu Chang; Zhiyu Wang
Journal:  Cell Death Dis       Date:  2020-06-11       Impact factor: 8.469

5.  Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells.

Authors:  Andrew Sulaiman; Sarah McGarry; Ka Mien Lam; Sara El-Sahli; Jason Chambers; Shelby Kaczmarek; Li Li; Christina Addison; Jim Dimitroulakos; Angel Arnaout; Carolyn Nessim; Zemin Yao; Guang Ji; Haiyan Song; Sheng Liu; Ying Xie; Suresh Gadde; Xuguang Li; Lisheng Wang
Journal:  Cell Death Dis       Date:  2018-07-26       Impact factor: 8.469

Review 6.  The emerging role of circular RNAs in breast cancer.

Authors:  Si-Ying Zhou; Wei Chen; Su-Jin Yang; Zi-Han Xu; Jia-Hua Hu; He-da Zhang; Shan-Liang Zhong; Jin-Hai Tang
Journal:  Biosci Rep       Date:  2019-06-25       Impact factor: 3.840

Review 7.  Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance.

Authors:  Saeedeh Keyvani-Ghamsari; Khatereh Khorsandi; Azhar Rasul; Muhammad Khatir Zaman
Journal:  Clin Epigenetics       Date:  2021-05-29       Impact factor: 6.551

8.  HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.

Authors:  Yuanyuan Yan; Fangxiao Liu; Li Han; Lin Zhao; Jianjun Chen; Olufunmilayo I Olopade; Miao He; Minjie Wei
Journal:  J Exp Clin Cancer Res       Date:  2018-10-19

9.  CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/STAT3 signaling.

Authors:  Renlun Huang; Shengqi Wang; Neng Wang; Yifeng Zheng; Jianfu Zhou; Bowen Yang; Xuan Wang; Juping Zhang; Lang Guo; Shusheng Wang; Zhiqiang Chen; Zhiyu Wang; Songtao Xiang
Journal:  Cell Death Dis       Date:  2020-04-16       Impact factor: 8.469

10.  Biological Functions and Identification of Novel Biomarker Expressed on the Surface of Breast Cancer-Derived Cancer Stem Cells via Proteomic Analysis.

Authors:  Eun-Young Koh; Ji-Eun You; Se-Hwa Jung; Pyung-Hwan Kim
Journal:  Mol Cells       Date:  2020-04-30       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.